Every so often, we receive an email that stops us cold. Not because it is dramatic. Not because it is careless. Because it feels impossible. Sheri M. from Georgia recently wrote to us with this ...
Sermorelin.com has officially launched a new telehealth platform dedicated to sermorelin therapy, responding to the growing interest among clinicians in combining sermorelin with GLP-1 protocols. This ...
A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...
A little known security feature on iPhones is in the spotlight after it stymied efforts by U.S. federal authorities to search devices seized from a reporter. Apple’s Lockdown Mode recently prevented ...
Regulatory alignment from the FDA and MD Anderson IRB supports resumption of enrollment in a U.S./European proof-of-concept tasquinimod study for myelofibrosis. Protocol changes introduce a more ...
NEW YORK, Feb 10 (Reuters) - U.S. power consumption, which hit its second straight record high in 2025, will rise further in 2026 and 2027, the Energy Information Administration said in its Short-Term ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** While the internet offers quick ...
CHICAGO--(BUSINESS WIRE)--ComEd today announced the first set of new Transmission Security Agreements (TSAs) designed to protect customers and ensure fairness in the cost of connecting and providing ...
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia (AML) overcome resistance to one of the most ...
If you've felt like the New Orleans Saints offensive line has been a weakness this year, you'd be right. Much of that is due to injuries rotating players in and out of the lineup all season long.
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...
Rybrevant Faspro is a new under-the-skin (subcutaneous) injection form of the cancer medicine Rybrevant (amivantamab). The FDA has now approved it in combination with another medicine called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results